FDA Brief

Warning letters Drugs

FDA warning letter to

Aesthetic Essentials Limited

High riskIssued Nov 3, 2025Posted Nov 5, 2025Center for Drug Evaluation and Research (CDER)

Hong Kong company Aesthetic Essentials Limited sells not-FDA-approved, mislabeled injectable botulinum toxin drugs online to U.S. consumers.

What happened

FDA found the violations by reviewing the company's website at www.aesthetic-essentials.com. FDA said the site offered injectable botulinum toxin drugs for sale to U.S. consumers, including a product marketed as "Rentox 200U" with claims for blepharospasm, hyperhidrosis, and cervical dystonia. FDA called these not-FDA-approved new drugs and misbranded drugs (labeling lacks adequate directions for use).

What FDA found

  1. The website offers "Rentox 200U," a botulinum toxin type A drug, for sale to U.S. consumers without an FDA-approved drug application.

    FD&C Act § 505(a) [21 U.S.C. § 355(a)]
  2. By offering this product online, the company causes an unapproved drug to be introduced into interstate commerce.

    FD&C Act § 301(d) [21 U.S.C. § 331(d)]
  3. The labeling for the prescription botulinum toxin product does not give adequate directions for a layperson to use it safely, so the drug is misbranded.

    FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]
  4. The product is not exempt from the adequate-directions requirement because it is not FDA-approved.

    21 CFR 201.115(a)
  5. By offering the misbranded drug for sale to U.S. consumers, the company causes it to be introduced into interstate commerce.

    FD&C Act § 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA requests that www.aesthetic-essentials.com cease offering any unapproved and misbranded drugs for sale to U.S. consumers. It asks for a written response within 15 working days describing steps taken to address violations and prevent recurrence.

Who should pay attention

  • online sellers of injectable cosmetic drugs
  • clinics and consumers buying imported botulinum toxin
  • distributors and brands sourcing aesthetic injectables

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk